Conavi Medical (CNVI) Stock Statistics & Valuation Metrics

Conavi Medical has a market cap or net worth of CAD 13.54M. The enterprise value is CAD 39.89M.

Market Cap

CAD 13.54M

Enterprise Value

CAD 39.89M

Conavi Medical has 119,857,994 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

119,857,994

Owned by Insiders

18.19%

Owned by Institutions

0.00%

Conavi Medical’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-5.83M

Employee Count

4

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, Conavi Medical had revenue of ― and earned -23.32M in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

-27.53M

Pretax Income

―

Net Income

-23.32M

EBITDA

-27.50M

Earnings Per Share (EPS)

―

Beta

0.04

52-Week Price Change

-81.17%

50-Day Moving Average

0.14

200-Day Moving Average

0.27

Relative Strength Index (RSI)

36.98

Average Volume (3m)

148.30K

Conavi Medical upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 27, 2026

Next Earnings Date

Dec 17, 2026

Ex-Dividend Date

―

Conavi Medical has ― in cash and marketable securities with CAD 2.12M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

CAD 2.12M

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for Conavi Medical is CAD 1.30, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

CAD 1.30

Price Target Upside

1050.44% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

―

EPS Growth Forecast

―